FDA decision sets up for growth in U.S. FDA clearance for expanded U.S. menu combined with encouraging progress across Europe and focus organisation, positions Q-linea for growth during the second hal ...
The S&P/ASX 200 is set for a flattish open, while major US benchmarks closed broadly higher overnight. Here are today's top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results